Skip to main content

Latest SEC Filings — Page 132

Most recent SEC EDGAR filings across all covered tickers, sorted chronologically. Wiseek AI reads each filing and scores it 1–10 for market-moving potential; click through for full analysis.

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.

Board Faces Contested Election; Urges Shareholders to Reject Dissident Nominee
ProForm PRE 14ASABA · Form PRE 14A · 2026-06-10
Board Faces Contested Election as Activist Shareholder Nominates Dissident Trustee
ProForm PRE 14ABRW · Form PRE 14A · 2026-06-10
RadNet Secures $250M Incremental Term Loan, Reduces Interest Rates on Credit Facilities
ProForm 8-KRDNT · Form 8-K · 2026-06-10
Tango Therapeutics Finalizes $600M Public Offering at Premium Price, Extends Cash Runway to 2030
ProForm 8-KTNGX · Form 8-K · 2026-06-10
Tango Therapeutics Prices Upsized $600M Public Offering at Premium Following Strong Clinical Data
ProForm 424B5TNGX · Form 424B5 · 2026-06-10
PureCycle Technologies Announces $395M Concurrent Equity and Convertible Note Offerings
ProForm 424B5PCT · Form 424B5 · 2026-06-10
Shareholders Approve 1.51M Share Increase to Stock Incentive Plan, Authorizing Significant Future Dilution
ProForm 8-KCCSI · Form 8-K · 2026-06-10
Shareholders Approve Equity Plans Authorizing Over 30% Potential Dilution
ProForm 8-KFENC · Form 8-K · 2026-06-10
Shareholder Vote Scheduled for Ligand Pharmaceuticals Acquisition at $39.00 Cash Plus Contingent Value Right
Form DEFM14AXOMA · Form DEFM14A · 2026-06-10
Largest Shareholder Al Shams Escalates Proxy Fight, Accuses Board of Entrenchment Tactics
ProForm DFAN14ABHR · Form DFAN14A · 2026-06-10
Takeover Bid for Pacific Booker Minerals Terminated Due to Dilutive Placement
ProForm 425AMEGF · Form 425 · 2026-06-10
American Eagle Gold details reason for terminating Pacific Booker takeover bid
ProForm SC14D1F/AAMEGF · Form SC14D1F/A · 2026-06-10
Netcapital Secures $150K in Highly Dilutive Convertible Debt Amidst Financial Distress
ProForm 8-KNCPL · Form 8-K · 2026-06-10
Genco Rejects Diana's $24.80 Tender Offer, Urges Shareholders to Vote Against Hostile Takeover
ProForm SC 14D9/AGNK · Form SC 14D9/A · 2026-06-10
AllianceBernstein Reports 2% AUM Increase to $899 Billion in May
Form 8-KAB · Form 8-K · 2026-06-10
Aethlon Medical Reports Going Concern Doubt, Significant Dilution, and Nasdaq Listing Risk
ProForm 10-KAEMD · Form 10-K · 2026-06-10
Shareholders Approve Issuance of $25.9M in Common Stock to CEO Robert McEwen
ProForm 8-KMUX · Form 8-K · 2026-06-10
Tectonic Therapeutic Completes Enrollment in Key Phase 2 Clinical Trial for TX45
Form 8-KTECX · Form 8-K · 2026-06-10
Ambev Reports $181 Million in Share Repurchases During May
Form 6-KABEV · Form 6-K · 2026-06-10
Genco Urges Shareholders to Reject Diana's $24.80 Tender Offer, Citing Proxy Firm Support
ProForm DEFA14AGNK · Form DEFA14A · 2026-06-10
Shareholders Approve Texas Reincorporation and Potential $150M Preferred Stock Conversion
ProForm 8-KDFH · Form 8-K · 2026-06-10
Swarmer Secures $150M At-The-Market Equity Facility with Deep Discount Potential
ProForm 8-KSWMR · Form 8-K · 2026-06-10
Summit Midstream Secures Major Pipeline Commitments, Advances 50% Capacity Expansion
ProForm 8-KSMC · Form 8-K · 2026-06-10
Activist Al Shams Accuses Braemar Board of Manipulating Director Nomination Process
ProForm SCHEDULE 13D/ABHR · Form SCHEDULE 13D/A · 2026-06-10
Annual Meeting Proxy Reveals Major Cost Cuts and No CEO Bonus Amid Financial Challenges
ProForm DEF 14ABRNS · Form DEF 14A · 2026-06-10
Bitmine Finalizes $350M Preferred Stock Offering with 9.5% Cumulative Dividend and Asset Sale Clause
ProForm 8-KBMNR · Form 8-K · 2026-06-10
Syndax Pharmaceuticals Closes $250M Convertible Senior Notes Offering
ProForm 8-KSNDX · Form 8-K · 2026-06-10
BancFirst Announces Acquisition of SpiritBank, Adding Nearly $1 Billion in Assets
ProForm 8-KBANF · Form 8-K · 2026-06-10
Tandy Leather Board Approves Immediate RSU Vesting, Increases Director Cash Retainers
Form 8-KTLF · Form 8-K · 2026-06-10
10% Owner Luxor Capital Plans Further Share Sales Amidst Ongoing Distribution
Form 144MRDN · Form 144 · 2026-06-10